年龄和阿尔茨海默氏症影响功能连接,沿着功能性大脑组织的单独轴的功能连接
Jonathan Rittmo1, Nicolai Franzmeier2,3,4, Olof Strandberg5
1Department of Clinical Sciences Malmö, Faculty of Medicine, SciLifeLab, Lund University, Lund, Sweden.
bioRxiv : the preprint server for biology
|July 15, 2025
概括
健康的衰老和阿尔茨海默病 (AD) 显示出不同的大脑连接模式. 早期的AD影响感官关联网络,而衰老影响执行网络,影响整个生命周期的认知.
科学领域:
- 神经科学是一个神经科学.
- 认知科学 认知科学
- 衰老研究研究 衰老研究
背景情况:
- 衰老和阿尔茨海默病 (AD) 与功能连接 (FC) 的改变有关,但模式仍在争论中.
- 整个皮层的功能梯度提供了一个研究这些FC变化的框架.
研究的目的:
- 调查功能连接性改变的空间和时间特征在老化和AD.
- 确定功能梯度如何与衰老和AD进展中的认知变化有关.
主要方法:
- 使用功能梯度对两个独立队列 (BioFINDER-2,N=973;ADNI,N=129) 的分析.
- 纵向和非线性分析以跟踪AD病理积累的变化.
- 功能连接模式与认知表现的相关性.
主要成果:
- 老龄化和AD中的过度和低连接性沿着两个不同的大脑轴形成一致的空间模式.
- 早期的AD病理与感觉关联轴的变化相关,这些变化会恶化认知能力,但在晚期的AD消失.
- 高龄,独立于AD,与整个生命周期的执行-非执行轴变化有关.
结论:
- 大脑内在的功能组织在大脑如何应对衰老和AD方面发挥着关键作用.
- 沿着特定梯度的功能连接模式可能代表对认知应变的一般神经反应.
- 这些发现有助于调和先前关于衰老和AD相关的大脑变化的研究中的差异.
相关概念视频
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673
Role of Cerebellum and Prefrontal Cortex in Memory
594
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
594
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263
Cognitive Development During Adulthood
289
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
289
Dementia
169
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
169


